We are live on ! Find out more
CS

Candriam SCA Portfolio holdings

AUM $19.3B
1-Year Est. Return 39.18%
This Fund
S&P 500
This Quarter Est. Return
+11.68%
1 Year Est. Return
+39.18%
3 Year Est. Return
+109.85%
5 Year Est. Return
+149.31%
10 Year Est. Return
+617.16%
AUM
$19.1B
AUM Growth
+$1.76B
Cap. Flow
+$154M
Cap. Flow %
0.81%
Top 10 Hldgs %
32.12%
Holding
703
New
28
Increased
257
Reduced
281
Closed
39

Top Buys

Rank Stock Value
1
NU icon
Nu Holdings
NU
+$60.7M
2
JNJ icon
Johnson & Johnson
JNJ
+$58.3M
3
SCHW
Charles Schwab
SCHW
+$54M
4
ABBV icon
AbbVie
ABBV
+$52.9M
5
PANW icon
Palo Alto Networks
PANW
+$42.9M

Top Sells

Rank Stock Value
1
NVDA icon
NVIDIA
NVDA
+$92.7M
2
EMR icon
Emerson Electric
EMR
+$57.2M
3
MELI icon
Mercado Libre
MELI
+$48.9M
4
AVGO icon
Broadcom
AVGO
+$38.9M
5
MU icon
Micron Technology
MU
+$37.7M

Sector Composition

Rank Sector Weight
1 Technology 36.63%
2 Healthcare 23.08%
3 Financials 11.48%
4 Consumer Discretionary 7.78%
5 Communication Services 6.93%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
TPL icon
551
Texas Pacific Land
TPL
$26.9B
$1.11M 0.01%
3,564
-1,152
-24% -$363K
CNC icon
552
Centene
CNC
$30.5B
$1.11M 0.01%
31,027
-5,453
-15% -$165K
TW icon
553
Tradeweb Markets
TW
$23B
$1.07M 0.01%
9,637
-2,070
-18% -$266K
BURL icon
554
Burlington
BURL
$23.4B
$1.06M 0.01%
4,156
+400
+11% +$109K
PKG icon
555
Packaging Corp of America
PKG
$22.2B
$1.05M 0.01%
4,835
DVN icon
556
Devon Energy
DVN
$51.3B
$1.04M 0.01%
29,544
-464
-2% -$15.8K
AGCO icon
557
AGCO
AGCO
$8.41B
$1M 0.01%
9,350
-1,935
-17% -$214K
TER icon
558
Teradyne
TER
$50B
$983K 0.01%
7,140
+603
+9% +$65.9K
DKNG icon
559
DraftKings
DKNG
$12.2B
$970K 0.01%
25,944
+3,683
+17% +$163K
CHTR icon
560
Charter Communications
CHTR
$17.3B
$966K 0.01%
3,512
-2,380
-40% -$719K
NOMD icon
561
Nomad Foods
NOMD
$1.77B
$964K 0.01%
73,301
-29,476
-29% -$462K
ARE icon
562
Alexandria Real Estate Equities
ARE
$9.37B
$960K 0.01%
11,517
-1,644
-12% -$132K
MLTX icon
563
MoonLake Immunotherapeutics
MLTX
$1.56B
$958K 0.01%
133,642
-11,188
-8% -$583K
MOS icon
564
The Mosaic Company
MOS
$7.19B
$924K ﹤0.01%
26,654
+2,952
+12% +$102K
BN icon
565
Brookfield
BN
$102B
$914K ﹤0.01%
19,979
+627
+3% +$27.8K
IOT icon
566
Samsara
IOT
$22.6B
$901K ﹤0.01%
24,181
+790
+3% +$29.3K
LOPE icon
567
Grand Canyon Education
LOPE
$4.22B
$874K ﹤0.01%
3,980
-3,145
-44% -$604K
BFAM icon
568
Bright Horizons
BFAM
$4.35B
$827K ﹤0.01%
7,615
FDS icon
569
Factset
FDS
$10B
$805K ﹤0.01%
2,809
-985
-26% -$376K
COO icon
570
Cooper Companies
COO
$14.2B
$793K ﹤0.01%
11,569
+1,769
+18% +$125K
KEY icon
571
KeyCorp
KEY
$23.8B
$785K ﹤0.01%
41,992
WPM icon
572
Wheaton Precious Metals
WPM
$49.7B
$776K ﹤0.01%
6,936
+853
+14% +$83.3K
CPAY icon
573
Corpay
CPAY
$25.7B
$767K ﹤0.01%
2,662
-1,853
-41% -$591K
AKAM icon
574
Akamai
AKAM
$15.6B
$761K ﹤0.01%
10,046
-3,471
-26% -$268K
HRL icon
575
Hormel Foods
HRL
$14.2B
$758K ﹤0.01%
30,646

Similar funds

Candriam SCA's Q3 2025 Portfolio in Review

As of Q3 2025, Candriam SCA held 703 positions worth $19.1B, up 10% from $17.3B the previous quarter. Its ten largest holdings account for 32% of the portfolio.

Candriam SCA's Q3 2025 filing shows 28 new, 257 increased, 281 reduced and 39 closed positions. Its largest new stake was Banco Macro: 322,600 shares worth $13.6M. The largest sale was NVIDIA, an estimated $92.7M.

By sector, the portfolio is most concentrated in Technology at 37% of assets, up from 36% a quarter earlier, followed by Healthcare and Financials.

  • Candriam SCA's largest Q3 2025 buy was Banco Macro: 322,600 shares worth $13.6M.
  • Candriam SCA added most to Nu Holdings in Q3 2025, an estimated $60.7M increase.
  • Candriam SCA's biggest Q3 2025 reduction was NVIDIA, cutting an estimated $92.7M.
  • Candriam SCA fully exited Verona Pharma in Q3 2025, selling an estimated $20.5M.
  • Candriam SCA's ten largest holdings make up 32% of its $19.1B portfolio in Q3 2025.
  • Candriam SCA opened 28 new positions and closed 39 in Q3 2025.
  • Candriam SCA's portfolio value rose 10% quarter-over-quarter to $19.1B.

Based on Candriam SCA's 13F filing for Q3 2025, filed 6 Nov 2025.